BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rhodes T, Lancaster K. Evidence-making interventions in health: A conceptual framing. Social Science & Medicine 2019;238:112488. [DOI: 10.1016/j.socscimed.2019.112488] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Grebely J, Cerdá M, Rhodes T. COVID-19 and the health of people who use drugs: What is and what could be? Int J Drug Policy 2020;83:102958. [PMID: 33183679 DOI: 10.1016/j.drugpo.2020.102958] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
2 Lancaster K, Rhodes T. What prevents health policy being 'evidence-based'? New ways to think about evidence, policy and interventions in health. Br Med Bull 2020;135:38-49. [PMID: 32897357 DOI: 10.1093/bmb/ldaa026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Larney S, Jones H, Rhodes T, Hickman M. Mapping drug epidemiology futures. Int J Drug Policy 2021;94:103378. [PMID: 34321152 DOI: 10.1016/j.drugpo.2021.103378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ellis J, Vassilev I, James E, Rogers A. Implementing a social network intervention: can the context for its workability be created? A quasi-ethnographic study. Implement Sci Commun 2020;1:93. [PMID: 33123686 DOI: 10.1186/s43058-020-00087-5] [Reference Citation Analysis]
5 Jenkins E, Slemon A, Morris H, Hyshka E, Schulz P, Haines-Saah RJ. Bereaved mothers' engagement in drug policy reform: A multisite qualitative analysis. Int J Drug Policy 2021;91:103011. [PMID: 33127282 DOI: 10.1016/j.drugpo.2020.103011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maat H, Balabanova D, Mokuwa E, Richards P, Mohan V, Ssengooba F, Twinomuhangi R, Woldie M, Mayhew S. Towards Sustainable Community-Based Systems for Infectious Disease and Disaster Response; Lessons from Local Initiatives in Four African Countries. Sustainability 2021;13:10083. [DOI: 10.3390/su131810083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rhodes T, Lancaster K. Futures-oriented drugs policy research: Events, trends, and speculating on what might become. Int J Drug Policy 2021;94:103332. [PMID: 34148724 DOI: 10.1016/j.drugpo.2021.103332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Davis MDM, Schermuly A, Smith AKJ, Newman C. Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people. BioSocieties. [DOI: 10.1057/s41292-022-00277-5] [Reference Citation Analysis]
9 Lindelauf J. Translating reports: School psychologists, knowledge-making and pedagogy. School Psychology International. [DOI: 10.1177/01430343221098267] [Reference Citation Analysis]
10 Donetto S, Desai A, Zoccatelli G, Allen D, Brearley S, Rafferty AM, Robert G. Patient experience data as enacted: Sociomaterial perspectives and 'singular-multiples' in health care quality improvement research. Sociol Health Illn 2021;43:1032-50. [PMID: 33834517 DOI: 10.1111/1467-9566.13276] [Reference Citation Analysis]
11 Lancaster K, Rhodes T. Futuring a world without disease: visualising the elimination of hepatitis C. Critical Public Health. [DOI: 10.1080/09581596.2020.1787347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Molldrem S, Smith AKJ. Reassessing the Ethics of Molecular HIV Surveillance in the Era of Cluster Detection and Response: Toward HIV Data Justice. Am J Bioeth 2020;20:10-23. [PMID: 32945756 DOI: 10.1080/15265161.2020.1806373] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
13 Rhodes T, Harris M, Sanín FG, Lancaster K. Ecologies of drug war and more-than-human health: The case of a chemical at war with a plant. International Journal of Drug Policy 2021;89:103067. [DOI: 10.1016/j.drugpo.2020.103067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 [DOI: 10.1101/2020.07.03.20145755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Duff C. A geology of drug morals. Int J Drug Policy 2021;88:103023. [PMID: 33202324 DOI: 10.1016/j.drugpo.2020.103023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Adams S, Rhodes T, Lancaster K. New directions for participatory modelling in health: Redistributing expertise in relation to localised matters of concern. Glob Public Health 2021;:1-15. [PMID: 34775919 DOI: 10.1080/17441692.2021.1998575] [Reference Citation Analysis]
17 Connelly S, Vanderhoven D, Rutherfoord R, Richardson L, Matthews P. Translating research for policy: the importance of equivalence, function, and loyalty. Humanit Soc Sci Commun 2021;8. [DOI: 10.1057/s41599-021-00873-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Watson TM, Kolla G, van der Meulen E, Dodd Z. Critical studies of harm reduction: Overdose response in uncertain political times. Int J Drug Policy 2020;76:102615. [PMID: 31837567 DOI: 10.1016/j.drugpo.2019.102615] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Wolfe D, Saucier R. Reprint of: Biotechnologies and the future of opioid addiction treatments. Int J Drug Policy 2021;94:103273. [PMID: 34391533 DOI: 10.1016/j.drugpo.2021.103273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rhodes T, Lancaster K. Evidence-making hepatitis C cure: Towards a science that knows more carefully. Int J Drug Policy 2019;72:40-6. [PMID: 31307851 DOI: 10.1016/j.drugpo.2019.06.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
21 Pienaar K, Petersen A, Bowman DM. Managing risks or generating uncertainties? Ambiguous ontologies of testing in Australian healthcare. Health (London) 2021;25:669-87. [PMID: 32186208 DOI: 10.1177/1363459320912830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Rhodes T, Lancaster K. Mathematical models as public troubles in COVID-19 infection control: following the numbers. Health Sociol Rev 2020;29:177-94. [PMID: 33411652 DOI: 10.1080/14461242.2020.1764376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
23 Perri M, Strike C. The missing link: Incorporating behaviour change theories in overdose education and naloxone distribution programs. Int J Drug Policy 2020;83:102853. [PMID: 32688261 DOI: 10.1016/j.drugpo.2020.102853] [Reference Citation Analysis]
24 Harris M, Guy D, Picchio CA, White TM, Rhodes T, Lazarus JV. Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research. Int J Drug Policy 2021;:103320. [PMID: 34261587 DOI: 10.1016/j.drugpo.2021.103320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Massazza A, May CR, Roberts B, Tol WA, Bogdanov S, Nadkarni A, Fuhr DC. Process evaluations of mental health and psychosocial support interventions for populations affected by humanitarian crises. Soc Sci Med 2022;303:114994. [PMID: 35561423 DOI: 10.1016/j.socscimed.2022.114994] [Reference Citation Analysis]
26 Mills T, Shannon R, O’hara J, Lawton R, Sheard L. Development of a ‘real-world’ logic model through testing the feasibility of a complex healthcare intervention: the challenge of reconciling scalability and context-sensitivity. Evaluation. [DOI: 10.1177/13563890211068869] [Reference Citation Analysis]
27 Parkin S, Neale J, Brown C, Jones JD, Brandt L, Castillo F, Campbell ANC, Strang J, Comer SD. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City. Int J Drug Policy 2021;87:102968. [PMID: 33096365 DOI: 10.1016/j.drugpo.2020.102968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wolfe D, Saucier R. Biotechnologies and the future of opioid addiction treatments. Int J Drug Policy 2021;88:103041. [PMID: 33246267 DOI: 10.1016/j.drugpo.2020.103041] [Reference Citation Analysis]
29 Rhodes T, Lancaster K. Excitable models: Projections, targets, and the making of futures without disease. Sociol Health Illn 2021;43:859-80. [PMID: 33942914 DOI: 10.1111/1467-9566.13263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Reddon H, Kerr T, Milloy MJ. Ranking evidence in substance use and addiction. Int J Drug Policy 2020;83:102840. [PMID: 32645584 DOI: 10.1016/j.drugpo.2020.102840] [Reference Citation Analysis]
31 Duff C. On the legacy of normalization. Addiction 2020;115:1378-81. [PMID: 32032446 DOI: 10.1111/add.15000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Rhodes T, Lancaster K. How to think with models and targets: Hepatitis C elimination as a numbering performance. Int J Drug Policy 2021;88:102694. [PMID: 32245664 DOI: 10.1016/j.drugpo.2020.102694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
33 Valentine K, Seear K. Commentary on Alex Stevens (2020) Critical realism and the 'ontological politics of drug policy'. Int J Drug Policy 2020;84:102879. [PMID: 32795879 DOI: 10.1016/j.drugpo.2020.102879] [Reference Citation Analysis]
34 Cooper HL, Cloud DH, Freeman PR, Fadanelli M, Green T, Van Meter C, Beane S, Ibragimov U, Young AM. Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky. Int J Drug Policy 2020;85:102701. [PMID: 32223985 DOI: 10.1016/j.drugpo.2020.102701] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
35 Stevens A. Critical realism and the ‘ontological politics of drug policy’. International Journal of Drug Policy 2020;84:102723. [DOI: 10.1016/j.drugpo.2020.102723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
36 Goodhand J, Meehan P, Bhatia J, Ghiabi M, Sanín FG. Critical policy frontiers: The drugs-development-peacebuilding trilemma. International Journal of Drug Policy 2021;89:103115. [DOI: 10.1016/j.drugpo.2021.103115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
37 Rhodes T, Lancaster K. Making pandemics big: On the situational performance of Covid-19 mathematical models. Soc Sci Med 2022;301:114907. [PMID: 35303668 DOI: 10.1016/j.socscimed.2022.114907] [Reference Citation Analysis]
38 Ekendahl M, Karlsson P. Fixed and fluid at the same time: how service providers make sense of relapse prevention in Swedish addiction treatment. Critical Public Health. [DOI: 10.1080/09581596.2021.1951170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Betsos A, Valleriani J, Boyd J, Mcneil R. Beyond Co-Production: The construction of drug checking knowledge in a canadian supervised injection facility. Social Science & Medicine 2022. [DOI: 10.1016/j.socscimed.2022.115229] [Reference Citation Analysis]
40 Duff C. WITHDRAWN: A Geology of Drug Morals. International Journal of Drug Policy 2020. [DOI: 10.1016/j.drugpo.2020.102852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Stratil JM, Voss M, Arnold L. WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19. BMJ Glob Health 2020;5:e003699. [PMID: 33234529 DOI: 10.1136/bmjgh-2020-003699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
42 Dennis F, Rhodes T, Harris M. More-than-harm reduction: Engaging with alternative ontologies of 'movement' in UK drug services. Int J Drug Policy 2020;82:102771. [PMID: 32513623 DOI: 10.1016/j.drugpo.2020.102771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Schroeder SE, Bourne A, Doyle JS, Hellard ME, Stoové M, Pedrana A. Constructing a 'target population': A critical analysis of public health discourse on substance use among gay and bisexual men, 2000-2020. Int J Drug Policy 2022;108:103808. [PMID: 35914477 DOI: 10.1016/j.drugpo.2022.103808] [Reference Citation Analysis]
44 Corcoran T, Edward Thomas MK. School-wide positive behaviour support as evidence-making interventions. Research in Education 2021;111:108-25. [DOI: 10.1177/00345237211034884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Paparini S, Papoutsi C, Murdoch J, Green J, Petticrew M, Greenhalgh T, Shaw SE. Evaluating complex interventions in context: systematic, meta-narrative review of case study approaches. BMC Med Res Methodol 2021;21:225. [PMID: 34689742 DOI: 10.1186/s12874-021-01418-3] [Reference Citation Analysis]
46 Rhodes T, Lancaster K, Lees S, Parker M. Modelling the pandemic: attuning models to their contexts. BMJ Glob Health 2020;5:e002914. [PMID: 32565430 DOI: 10.1136/bmjgh-2020-002914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
47 Fraser S. Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences. International Journal of Drug Policy 2020;82:102610. [DOI: 10.1016/j.drugpo.2019.102610] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
48 Barnett A, Savic M, Pienaar K, Carter A, Warren N, Sandral E, Manning V, Lubman DI. Enacting 'more-than-human' care: Clients' and counsellors' views on the multiple affordances of chatbots in alcohol and other drug counselling. Int J Drug Policy 2021;94:102910. [PMID: 33059955 DOI: 10.1016/j.drugpo.2020.102910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]